NRIX — NURIX THERAPEUTICS

Ownership history in GENERAL ATLANTIC, L.P.  ·  1 quarter on record

This page tracks every 13F SEC filing in which GENERAL ATLANTIC, L.P. reported a position in NURIX THERAPEUTICS (NRIX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.23% (2025 Q4)
Avg. % of fund
3.23%
First filed
2025 Q4
Last filed
2025 Q4
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 INITIATED 4,897,159 — — 3.23% $92.9M $18.97
% of Fund (quarterly)    NRIX price (monthly, adj. close)

Other funds also holding NRIX

As of 2025 Q4 — sorted by position size

Redmile Group, LLC 3Y 7Y 11.31% Vestal Point Capital, LP 3.02% Commodore Capital LP 3Y 2.87% Elmind Capital, LP 2.58% Kynam Capital Management, LP 3Y 2.39% Deep Track Capital, LP 3Y 2.38% Longaeva Partners L.P. 1.48% BRAIDWELL LP 3Y 1.32% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.2% FLAX POND CAPITAL, LLC 1.13%
← Back to GENERAL ATLANTIC, L.P. Holdings